Keywords: Fosun Pharma, Hunan Dongting, Equity stake, China

Fosun Pharma acquires majority stake in Dongting for $93 million

Article | 14 January 2013

Shanghai, China-based Fosun Pharma says that it has acquired 77.8% stake in central nervous system and hemostatic drugmaker Hunan Dongting for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Fosun Pharma

Hunan Dongting

Go to company listing